{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:30:31Z","timestamp":1793503831763,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005298","name":"Universidad de Costa Rica","doi-asserted-by":"publisher","award":["VI-741-B5-602"],"award-info":[{"award-number":["VI-741-B5-602"]}],"id":[{"id":"10.13039\/501100005298","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.toxicon.2018.11.292","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T12:22:11Z","timestamp":1542198131000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Neutralizing properties of LY315920 toward snake venom group I and II myotoxic phospholipases A2"],"prefix":"10.1016","volume":"157","author":[{"given":"Wendy","family":"Bryan-Quir\u00f3s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e1n","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8385-3081","authenticated-orcid":false,"given":"Jos\u00e9 Mar\u00eda","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2419-6469","authenticated-orcid":false,"given":"Bruno","family":"Lomonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2018.11.292_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.toxicon.2017.04.001","article-title":"Peptidomimetic hydroxamate metalloproteinase inhibitors abrogate local and systemic toxicity induced by Echis ocellatus (saw-scaled) snake venom","volume":"132","author":"Arias","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.11.292_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.toxicon.2007.10.008","article-title":"Ability of fucoidan to prevent muscle necrosis induced by snake venom myotoxins: comparison of high- and low-molecular weight fractions","volume":"51","author":"Azofeifa","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.11.292_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/15563650903356201","article-title":"Compartment syndrome after Bothrops jararaca snakebite: monitoring, treatment, and outcome","volume":"48","author":"Bucaretchi","year":"2010","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.toxicon.2018.11.292_bib4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/BCJ20160577","article-title":"Venomics: integrative venom proteomics and beyond","volume":"474","author":"Calvete","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.toxicon.2018.11.292_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.toxicon.2018.04.015","article-title":"Toxin-resolved antivenomics-guided assessment of the immunorecognition landscape of antivenoms","volume":"148","author":"Calvete","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.11.292_bib6","first-page":"515","article-title":"Snake-bites: appraisal of the global situation","volume":"76","author":"Chippaux","year":"1998","journal-title":"Bull. W.H.O."},{"key":"10.1016\/j.toxicon.2018.11.292_bib7","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1021\/cr200085w","article-title":"Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention","volume":"111","author":"Dennis","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.toxicon.2018.11.292_bib8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0002-9440(10)65291-1","article-title":"Nerve terminal damage by \u03b2-bungarotoxin: its clinical significance","volume":"154","author":"Dixon","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.toxicon.2018.11.292_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0006-2952(00)00302-6","article-title":"Effectiveness of Batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper","volume":"60","author":"Escalante","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxicon.2018.11.292_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1432-1033.1993.tb17946.x","article-title":"Comparison of crotoxin isoforms reveals that stability of the complex plays a major role in its pharmacological action","volume":"214","author":"Faure","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.toxicon.2018.11.292_bib11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jmb.2011.07.027","article-title":"Crystal structure of crotoxin reveals key residues involved in the stability and toxicity of this potent heterodimeric \u03b2-neurotoxin","volume":"412","author":"Faure","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.toxicon.2018.11.292_bib12","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1021\/pr101091a","article-title":"Venomic and antivenomic analyses of the Central American coral snake, Micrurus nigrocinctus (Elapidae)","volume":"10","author":"Fern\u00e1ndez","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.toxicon.2018.11.292_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0041-0101(65)90020-6","article-title":"The effect of EDTA on the extent of tissue damage caused by the venoms of Bothrops atrox and Agkistrodon piscivorus","volume":"2","author":"Flowers","year":"1965","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.11.292_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0041-0101(84)90144-2","article-title":"Isolation of a myotoxin from Bothrops asper venom: partial characterization and action on skeletal muscle","volume":"22","author":"Guti\u00e9rrez","year":"1984","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.11.292_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0742-8413(86)90183-0","article-title":"Pharmacological activities of a toxic phospholipase A isolated from the venom of the snake Bothrops asper","volume":"84","author":"Guti\u00e9rrez","year":"1986","journal-title":"Comp. Biochem. Physiol. C"},{"key":"10.1016\/j.toxicon.2018.11.292_bib16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.toxicon.2007.08.007","article-title":"Systemic and local myotoxicity induced by snake venom group II phospholipases A2: comparison between crotoxin and a Lys49 PLA2 homologue","volume":"51","author":"Guti\u00e9rrez","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.11.292_bib17","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1371\/journal.pntd.0000569","article-title":"Snake envenoming: a disease of poverty","volume":"3","author":"Harrison","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.toxicon.2018.11.292_bib18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4269\/ajtmh.17-0922","article-title":"Snakebite: an exploratory cost-effectiveness analysis of adjunct treatment strategies","volume":"99","author":"Herzel","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2018.11.292_bib19","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1371\/journal.pmed.0050218","article-title":"The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths","volume":"5","author":"Kasturiratne","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.toxicon.2018.11.292_bib20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/toxins8090248","article-title":"LY315920 Appears to be a potent, broad-spectrum, inhibitor of snake venom phospholipase A2 and a possible pre-referral treatment for envenomation","volume":"8","author":"Lewin","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2018.11.292_bib21","first-page":"647","article-title":"Phospholipases A2 from Viperidae snake venoms: how do they induce skeletal muscle damage?","volume":"58","author":"Lomonte","year":"2011","journal-title":"Acta Chim. Slov."},{"key":"10.1016\/j.toxicon.2018.11.292_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0041-0101(94)90020-5","article-title":"The dynamics of local tissue damage induced by Bothrops asper snake venom and myotoxin II on the mouse cremaster muscle: an intravital and electron microscopic study","volume":"32","author":"Lomonte","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.11.292_bib23","first-page":"31224","article-title":"Vulnerability to snakebite envenoming: a global mapping of hotspots","volume":"18","author":"Longbottom","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.toxicon.2018.11.292_bib24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0041-0101(93)90146-A","article-title":"Antagonism of the myotoxic effects of Bothrops jararacussu venom and bothropstoxin by polyanions","volume":"31","author":"Melo","year":"1993","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.11.292_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1388-1981(99)00157-2","article-title":"Structure-based design of a new class of anti-inflammatory drugs: secretory phospholipase A2 inhibitors","volume":"1441","author":"Mihelich","year":"1999","journal-title":"SPI. Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxicon.2018.11.292_bib26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/qjmed\/90.5.323","article-title":"Snake bites by the jararacu\u00e7u (Bothrops jararacussu): clinicopathological studies of 29 proven cases in S\u00e3o Paulo State, Brazil","volume":"90","author":"Milani","year":"1997","journal-title":"Q. J. Med."},{"key":"10.1016\/j.toxicon.2018.11.292_bib27","article-title":"Snakebite mortality in India: a nationally representative mortality survey","volume":"5","author":"Mohapatra","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.toxicon.2018.11.292_bib28","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1007\/s00018-008-8113-3","article-title":"Cellular pathology induced by snake venom phospholipase A2 myotoxins and neurotoxins: common aspects of their mechanisms of action","volume":"65","author":"Montecucco","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.toxicon.2018.11.292_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109846","article-title":"Synergism between basic Asp49 and Lys49 phospholipase A2 myotoxins of viperid snake venom in vitro and in vivo","volume":"9","author":"Mora-Obando","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.toxicon.2018.11.292_bib30","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.7717\/peerj.569","article-title":"Role of enzymatic activity in muscle damage and cytotoxicity induced by Bothrops asper Asp49 phospholipase A2 myotoxins: are there additional effector mechanisms involved?","volume":"2","author":"Mora-Obando","year":"2014","journal-title":"Peer J."},{"key":"10.1016\/j.toxicon.2018.11.292_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10557-011-6358-9","article-title":"Inhibition of secretory phospholipase A2 in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial","volume":"26","author":"Nicholls","year":"2012","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.toxicon.2018.11.292_bib32","doi-asserted-by":"crossref","first-page":"16604","DOI":"10.1021\/jacs.6b10950","article-title":"Engineering the protein corona of a synthetic polymer nanoparticle for broad-spectrum sequestration and neutralization of venomous biomacromolecules","volume":"138","author":"O'Brien","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.toxicon.2018.11.292_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cbi.2014.06.015","article-title":"The biflavonoid morelloflavone inhibits the enzymatic and biological activities of a snake venom phospholipase A2","volume":"220","author":"Perea\u00f1ez","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.toxicon.2018.11.292_bib34","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/BF00997027","article-title":"Biochemistry and pharmacology of the crotoxin complex","volume":"270","author":"R\u00fcbsamen","year":"1971","journal-title":"Naunyn-Schmiedebergs Arch. Pharmak."},{"key":"10.1016\/j.toxicon.2018.11.292_bib35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0041-0101(95)00162-X","article-title":"Neutralization of myonecrosis, hemorrhage, and edema induced by Bothrops asper snake venom by homologous and heterologous pre-existing antibodies in mice","volume":"34","author":"Rucavado","year":"1996","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.11.292_bib36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.biochi.2016.12.015","article-title":"Crystal structure of a phospholipase A2 from Bothrops asper venom: insights into a new putative \u201cmyotoxic cluster\u201d","volume":"133","author":"Salvador","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.toxicon.2018.11.292_bib37","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.toxicon.2010.01.011","article-title":"Crotoxin: novel activities for a classic \u03b2-neurotoxin","volume":"55","author":"Sampaio","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.11.292_bib38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4269\/ajtmh.1995.53.260","article-title":"Efficacy of antivenom in the treatment of severe local envenomation by the hump-nosed viper (Hypnale hypnale)","volume":"53","author":"Sellahewa","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2018.11.292_bib39","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0022-3565(24)38064-4","article-title":"Pharmacology of LY315920\/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: a new class of anti-inflammatory drugs","volume":"288","author":"Snyder","year":"1999","journal-title":"SPI. J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxicon.2018.11.292_bib40","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bbagen.2018.02.003","article-title":"Inhibition of Echis carinatus venom by DNA, a promising therapeutic molecule for snakebite management","volume":"1862","author":"Swethakumar","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxicon.2018.11.292_bib41","series-title":"Snake Venoms","first-page":"49","article-title":"Cellular mechanisms of action of snake phospholipase A2 toxins","author":"Tonello","year":"2015"},{"key":"10.1016\/j.toxicon.2018.11.292_bib42","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.toxicon.2014.11.224","article-title":"Inhibitory potential of three zinc chelating agents against the proteolytic, hemorrhagic, and myotoxic activities of Echis carinatus venom","volume":"93","author":"Urs","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.11.292_bib43","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3390\/molecules23020391","article-title":"Exploration of the inhibitory potential of Varespladib for snakebite envenomation","volume":"23","author":"Wang","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.toxicon.2018.11.292_bib44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0041-0101(92)90470-P","article-title":"Pathologic changes induced by phospholipase A2 isolated from the venom of Collett's snake, Pseudechis colletti: a light and electron microscopic study","volume":"30","author":"Weinstein","year":"1992","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.11.292_bib45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.toxicon.2017.12.047","article-title":"Local morbidity from red-bellied black snake (Pseudechis porphyriacus, Elapidae) envenoming: two cases and a brief review of management","volume":"142","author":"Weinstein","year":"2018","journal-title":"Toxicon"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010118310134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010118310134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T02:05:59Z","timestamp":1775268359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010118310134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":45,"alternative-id":["S0041010118310134"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2018.11.292","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutralizing properties of LY315920 toward snake venom group I and II myotoxic phospholipases A2","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2018.11.292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}